The Leukemia & Lymphoma Society Applauds Nobel Laureates in Medicine for their Work in Immunotherapy and its Potential for Cancer Patients

LLS is Available to Comment on the Significance of this Promise

Oct 03, 2011, 12:02 ET from The Leukemia & Lymphoma Society

WHITE PLAINS, N.Y., Oct. 3, 2011 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) congratulates Bruce Beutler, M.D., Jules Hoffmann, Ph.D., and Ralph Steinman, M.D., the three winners of the Nobel Prize in medicine announced this morning. The work for which they are being recognized formed the foundation of immunotherapy which holds great promise for the cancer community.

(Logo: )

As a leading nonprofit funder of cancer research, LLS can speak to the impact that their work has had on understanding the mechanisms that activate T-Cells, which play a key role in the body's immune system. These discoveries are already helping to advance vaccines and other immunotherapies for patients with cancer.

One of the original and key studies cited by the Nobel Assembly in their selection, "Identification of a Novel Cell Type if Peripheral Lymphoid Organs of Mice," in which the dendritic cell was discovered, was authored by Steinman in 1973, when he was a special fellow of The Leukemia & Lymphoma Society.

To arrange interviews with Louis DeGennaro, Ph.D., chief mission officer of LLS, please contact Andrea Greif at o: (914) 821-8958, c: (914) 772-3027 or

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.  

Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

SOURCE The Leukemia & Lymphoma Society